Malignant Biliary Tract Neoplasm — Trials

Malignant Biliary Tract Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,281 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 366
Recruiting: 208
Ph III recruiting: 19
Growth YoY: +14.8%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (152)

clinicaltrialsPublishedShowing 51–100 of 223 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05111574	Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery	active not recruiting	Phase 2	101	National Cancer Institute (NCI)NIH	2	Aug 4, 2026	clinicaltrials
NCT05564403	Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)	active not recruiting	Phase 2	66	National Cancer Institute (NCI)NIH	1	Aug 4, 2026